The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice
Open accessAbstract
Acetylcholine serves an important modulatory role in the central nervous system. Pharmacological evidence has suggested that cholinergic activity can modulate central dopaminergic transmission; however, the nature of this interaction and the receptors involved remain undefined. In this study we have generated mice lacking the M1 muscarinic acetylcholine receptor and examined the effects of M1 deletion on dopaminergic transmission and locomotor behavior. We report that M1 deficiency leads to elevated dopaminergic transmission in the striatum and significantly increased locomotor activity. M1-deficient mice also have an increased response to the stimulatory effects of amphetamine. Our results provide direct evidence for regulation of dopaminergic transmission by the M1 receptor and are consistent with the idea that M1 dysfunction could be a contributing factor in psychiatric disorders in which altered dopaminergic transmission has been implicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Self-citationCocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Neurotransmitters and neuromodulators in the basal ganglia
Graybiel, A. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90104-i · Cited by 1,576
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
Levey, A., Kitt, C., Simonds, W., Price, D., & Brann, M. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-10-03218.1991 · Cited by 918
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Simmons, D. M., Arriza, J. L., & Swanson, L. W. (1989) · Journal of Histotechnology · doi:10.1179/his.1989.12.3.169 · Cited by 871
Gerfen, C. R. (1984) · Nature · doi:10.1038/311461a0 · Cited by 837
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784
Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence
Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., & Carlsson, M. L. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.237 · Cited by 688
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 631
Self-citationProfound neuronal plasticity in response to inactivation of the dopamine transporter
Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4029 · Cited by 600
Self-citationThe Pharmacological. Basis of Therapeutics
Lee, L. E. (1955) · American Journal of Clinical Pathology · doi:10.1093/ajcp/25.12.1401a · Cited by 532
Molecular Biology of Muscarinic Acetylcholine Receptors
Wess, J. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.40 · Cited by 488
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.
Weiner, D. M., Levey, A. I., & Brann, M. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7050 · Cited by 480
Molecular Properties of the Muscarinic Acetylcholine Receptor
Nathanson, N. M. (1987) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.10.030187.001211 · Cited by 478
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions
Di Chiara, G., Morelli, M., & Consolo, S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90005-1 · Cited by 467
Acetylcholine-mediated modulation of striatal function
Calabresi, P., Centonze, D., Gubellini, P., Pisani, A., & Bernardi, G. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01501-5 · Cited by 440
Hersch, S., Gutekunst, C., Rees, H., Heilman, C., & Levey, A. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03351.1994 · Cited by 404
Wang, Y.-M., Gainetdinov, R. R., Fumagalli, F., Xu, F., Jones, S. R., Bock, C. B., Miller, G. W., Wightman, R. M., & Caron, M. G. (1997) · Neuron · doi:10.1016/s0896-6273(00)80419-5 · Cited by 376
Self-citationMiyakawa, T., Yamada, M., Duttaroy, A., & Wess, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05239.2001 · Cited by 370
Cloning and functional characterization of a cocaine‐sensitive dopamine transporter
Giros, B., El Mestikawy, S., Bertrand, L., & Caron, M. G. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81406-x · Cited by 368
Self-citationHamilton, S. E., Loose, M. D., Qi, M., Levey, A. I., Hille, B., McKnight, G. S., Idzerda, R. L., & Nathanson, N. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13311 · Cited by 366
Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes
Bernard, V, Normand, E., & Bloch, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03591.1992 · Cited by 327
Giorguieff, M. F., Le Floc'h, M. L., Glowinski, J., & Besson, M. J. (1977) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30804-9 · Cited by 237
Crook, J. M., Tomaskovic-Crook, E., Copolov, D. L., & Dean, B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.918 · Cited by 227
Genetic animal models: focus on schizophrenia
Gainetdinov, R. R., Mohn, A. R., & Caron, M. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01886-5 · Cited by 201
Self-citationYeomans, J. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00054-4 · Cited by 198
Beyond the Dopamine Hypothesis: The Neurochemical Pathology of Schizophrenia
Reynolds, G. P. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.155.3.305 · Cited by 168
Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals
De Belleroche, J., & Bradford, H. F. (1978) · Brain Research · doi:10.1016/0006-8993(78)90176-2 · Cited by 163
Compartmental origins of striatal efferent projections in the cat
Jiménez-Castellanos, J., & Graybiel, A. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90080-8 · Cited by 155
Dean, B., Crook, J. M., Opeskin, K., Hill, C., Keks, N. A., & Copolov, D. (1996) · PubMed · Cited by 149
Lehmann, J. C., & Langer, S. Z. (1982) · Brain Research · doi:10.1016/0006-8993(82)91147-7 · Cited by 136
Dewey, S. L., Smith, G. S., Logan, J., Brodie, J. D., Simkowitz, P., MacGregor, R. R., Fowler, J. S., Volkow, N. D., & Wolf, A. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11816 · Cited by 126
Elucidating the role of muscarinic receptors in psychosis
Felder, C. C., Porter, A. C., Skillman, T. L., Zhang, L., Bymaster, F. P., Nathanson, N. M., Hamilton, S. E., Gomeza, J., Wess, J., & McKinzie, D. L. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01059-1 · Cited by 120
Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain
Cerruti, C., Walther, D. M., Kuhar, M. J., & Uhl, G. R. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90187-t · Cited by 119
Xu, M., Mizobe, F., Yamamoto, T., & Kato, T. (1989) · Brain Research · doi:10.1016/0006-8993(89)90217-5 · Cited by 103
Westfall, T. C. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90266-5 · Cited by 83
Klippel, N. D., Sarre, S., Ebinger, G., & Michotte, Y. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90642-z · Cited by 78
Raiteri, M., Marchi, M., & Maura, G. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90296-5 · Cited by 77
Potential role of muscarinic receptors in schizophrenia
Bymaster, F. P., Shannon, H. E., Rasmussen, K., DeLapp, N. W., Ward, J. S., Calligaro, D. O., Mitch, C. H., Whitesitt, C. A., Ludvigsen, T. S., Sheardown, M. J., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(98)00597-9 · Cited by 54
Aramakis, V. B., Bandrowski, A. E., & Ashe, J. H. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990615)32:4<262::aid-syn3>3.0.co;2-j · Cited by 40
Kudernatsch, M., & Sutor, B. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90571-1 · Cited by 25
Cited by
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice
Anagnostaras, S. G., Murphy, G. G., Hamilton, S. E., Mitchell, S. L., Rahnama, N. P., Nathanson, N. M., & Silva, A. J. (2003) · Nature Neuroscience · doi:10.1038/nn992 · Cited by 544
Muscarinic acetylcholine receptors as CNS drug targets
Langmead, C. J., Watson, J., & Reavill, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.009 · Cited by 419
Metadata
- Authors
- Gerber, D. J., Sotnikova, T. D., Gainetdinov, R. R., Huang, S. Y., Caron, M. G., & Tonegawa, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 98
- Issue
- 26
- Pages
- 15312-15317
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2036398723
- Cited by
- 264
- References
- 46
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.